­

June 2016

New publication in the prestige “Journal of Arthroplasty” demonstrates that Using an IPCD and TXA and discontinuing enoxaparin and preoperative autologous blood donation eliminated blood transfusion in primary THA and TKA without any increase in VTED. Using an IPCD instead of enoxaparin, adding TXA, and eliminating preoperative autologous donation each had an incremental dose response [...]

June 2016

Activecare® gets additional evidence for its efficiency: New publication in the prestige “Journal of Arthroplasty” Confirming Patient Satisfaction, Safety, Efficacy and Reduction of Hospital Readmissions with ActiveCare® DVT prophylaxis Mobile Compression Device Following Joint Replacement Surgery. This was a prospective study of 3,143 patients undergoing primary or revision knee or hip arthroplasty. Study title: The Effectiveness [...]

ActiveCare®+S.F.T. is a cost effective VTE prevention compared to Enoxaparin After Total Hip Arthroplasty

Cost-Effectiveness of Venous Thromboembolism Prophylaxis With a New Mobile Device After Total Hip Arthroplasty C. Colwell, M. Froimson, M. Mont, M. Ritter, R.Trousdale, K. Buehler, A. Spitzer, T. Donaldson, D. Padgett. The Journal of Arthroplasty, September 2012; 27(8):1417-1584 Findings: Based on the SAFE study, this model was constructed to evaluate any difference in cost-effectiveness between ActiveCare®+SFT and [...]

The use of ActiveCare® yields significant decrease in serious bleeding

Thrombosis Prevention after Total Hip Arthroplasty: A Prospective Randomized Trial Comparing a Mobile Compression Device with Low Molecular Weight Heparin C. Colwell, M. Froimson, M. Mont, M. Ritter, R.Trousdale, K. Buehler, A. Spitzer, T. Donaldson, D. Padgett. The Journal of Bone and Joint Surgery, March 2010; 92(3): 527-535 See link to abstract Main results: Efficacy:  There [...]

ActiveCare® treatment was at least 2 times more effective than enoxaparin in preventing DVT

DVT Prevention in Joint Arthroplasties: Continuous Enhanced Circulation Therapy vs. Low Molecular Weight Heparin Y. Gelfer, H. Tavor, A. Or on, A. Peer, N. Halperin, D. Robinson. The Journal of Arthroplasty, February 2006; 21(2): 206-214 Main results: Efficacy: The C.E.C.T protocol was significantly more effective than enoxaparin in reducing DVT Safety: Safety profiles were similar in [...]

ActiveCare® +enxoparin is more effective than IPC +enxoparin

Venous Thromboembolic Disease Reduction with a Portable Pneumatic Compression Device M. Froimson, T. Murray, A. Fazekas Journal of Arthroplasty February 2009; 24(2): 310-316 Main results: Efficacy: The replacement of the standard IPC by ActiveCare® reduced VTE rate from 3.6% to 1.3%. Length of Stay: The average LOS was shorter for patients treated with ActiveCare® than those treated with IPC (4.2 [...]

ActiveCare®+Enoxaparin (vs Enoxaparin) – reduces DVT rates

Portable Compression Device and LMWH Compared with LMWH for Thromboprophylaxis after Total Joint Arthroplasty J. Edwards, P. Pulido, K. Ezzet, S. Copp, R. Walker,  C. Colwell Journal of Arthroplasty, December 2008; 23(8): 1122-1127 Results: Efficacy: The addition of ActiveCare® to enoxaparin reduced the DVT rate from 12% to 4% (66% relative risk reduction). Safety: The safety profile remained unchanged. [...]

Multicenter study on 3060 patients finds ActiveCare® mobile compression device to be as effective as blood thinners without bleeding complications

A Mobile Compression Device for Thrombosis Prevention in Hip and Knee Arthroplasty C. Colwell, M. Froimson, M. Mont, M. Ritter, R. Trousdale, K. Buehler, A. Spitzer, T. Donaldson, D. Padgett. The Journal of Bone and Joint Surgery, Feb 2014, 05;96(3):177-183 Read lead article http://jbjs.org/content/96/3/177 Read the commentary written on the article http://jbjs.org/content/96/3/e23.full-text.pdf+html Findings:  Use of the mobile compression device [...]

November 2015

Following the study presented at the American Association of Hip and Knee Surgeons 25th Annual Meeting that shows ActiveCare® Mobile Compression DVT Prophylaxis Following Total Joint Replacement Surgery Leads To Significant Hospitals Cost Reductions. M.D Richard Iorio talks study on VTE and synchronized mobile compression Watch video

November 2015

Medical Compression Systems Additional good news for #ORTHOPEDIC SURGEONS AND #HOSPITAL ADMINISTRATION: New Study Shows ActiveCare® Mobile Compression DVT Prophylaxis Following Total Joint Replacement Surgery Leads To SIGNIFICANT HOSPITALS COST REDUCTIONS link text

April 2015

Just released: New data further validating the use of the ActiveCare® DVT prophylaxis compression system following total joint replacement procedures. This study, selected as the best poster in the adult reconstruction category, was presented at the American Academy of Orthopedic Surgeons (AAOS) Annual Meeting. You are welcome to read more about it here

March 2015

ActiveCare took part at AAOS 2015 - American Academy of Orthopaedic Surgeons, that took place in Las Vegas, March 25-27. Many TJR surgeons gathered around our booth, learning how to prevent VTE in TJA patients with no major bleeding reported. Visitors at our booth participated in a survey dedicated to learn how TJR surgeons confront the risks of [...]